se of Procalcitonin in Diagnosing and Monitoring Diabetic Foot Osteomyelitis and Cellulitis at The Townsville Hospital–A Pilot Study

Not Applicable

Recruiting

• Conditions: Diabetes; Diabetic Foot infections; Foot Ulcer; Infection - Other infectious diseases; Metabolic and Endocrine - Diabetes; Skin - Other skin conditions

• Registration Number: ACTRN12617001164381
• Lead Sponsor: James Cook University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-08-08
• Last Update Posted: 18 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients meeting the following inclusion criteria will be eligible to enter the study:
1.Subjects with diabetic foot ulcer
2. Aged 18 years or over
3.Exclusion of other etiologies of foot ulcer.

Exclusion Criteria

Patients meeting any of the following criteria will not be included in the study:

1.Clinical infection at the studied ulcer site (bacterial and fungal)
2.Planned surgical intervention for the diabetic foot ulcer
3.Clinically significant lower-extremity ischemia (as defined by an ankle/brachial index of <0.65)
4.Significant medical conditions that would impair wound healing will also be excluded from the study. These conditions include hepatic, respiratory or cardiac failures, aplastic anemia, scleroderma and malignancy, treatment with immunosuppressive agents or steroids, myocardial infarcts, stroke, major surgery within 6 months of the study, or usage of tobacco
5.Ulcer of a non-diabetic pathophysiology (e.g., rheumatoid, radiation-related, and vasculitis-related ulcers, calciphylaxis or dystrophic calcinosis cutis)
6.Active malignancy other than basal cell carcinoma as well as subjects with cancerous or pre-cancerous lesions in the ulcer area
7.Pregnancy
8.Inability to comply with study protocol

Study & Design

• Study Type: Interventional
• Study Design: Not specified